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Abstract 
Background: Silicone oils of different 
viscosities are used in the treatment of retinal 
detachments of varying pathology. 
Method: Seventy-two cases of retinal 
detachments managed with silicone oil were 
reviewed in a retrospective chart analyses. Eighty 
nine patients were reviewed from which data on 
primary pathology, type of silicone oil, duration of 
oil “in situ” and complications (including 
emulsification, increased intraocular pressure (IOP), 
re-detachment, cataract and presence of CME) were 
compiled. Of this number, 72 patients with post-
operative follow-up of two years or more and 
documentation of the above parameters were 
included. The data was carefully analysed in an 
effort to determine the primary factor or factors of 
the varying silicone oil substitutes utilized 
responsible for the successful or non-successful re-
attachment of the retina. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results: Retinal re-detachment rate is greater 
when Silicone Oil (SO) is removed before 12 
months. Complex vs non-complex retinal re-
detachments in sub-group analysis indicates 
superiority of retention of SO for greater than 12 
months. Emulsification is greater in low viscosity 
SO (1300cts). 
Conclusion: The complication rates witnessed 
in this retrospective study are comparable to the 
findings of published studies present in the 
ophthalmic literature on an international scale. The 
findings of this study support the hypothesis that it 
is the duration of the SO “in situ” as opposed to the 
viscosity or other SO attributes which ultimately 
influences the re-detachment rate. 
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Introduction 
Retinal detachment is the separation of the 
neurosensory retina from the underlying retinal 
pigment epithelium (RPE). Retinal detachment 
repair was first described in 1920 by Gonin, and has 
since undergone several advancements.1 The 
ultimate success of re-attachment is dependent on 
sealing any breaks in the retina and ensuring there is 
no longer any traction between the vitreous and 
retina itself. Uncomplicated rhegmatogenous retinal 
detachments may be treated through a number of 
modalities, the likes of which include pneumatic 
retinopexy, scleral buckling and pars plana 
vitrectomy.2-3 Advancements in vitrectomy 
techniques coupled with the introduction of silicone 
oil have allowed for the treatment of more 
complicated retinal reattachments, resulting in 
higher success rates and lower rates of re-
detachment.  
Introduction of heavy silicone oil (HSO), 
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namely Densiron 68, has allowed for the 
management of inferior tears and recurrent re-
detachments due to its physical properties, allowing 
it to tamponade lower tears due to its greater 
specific gravity when compared to water.4-5 It is the 
purpose of this study to determine the 
complications associated with retinal detachment 
repair managed with silicone oil at Mater Dei 
Hospital, Malta, Europe, when compared to the 
results of similar studies on an international level. 
We also aim to demonstrate our hypothesis that it is 
the duration of silicone oil “in situ” rather than the 
viscosity or other attributes of silicone oil which 
ultimately influences the rate of re-detachment.  
 
 
Materials and Methods 
SO with viscosities of Oxane1300cts, 
Oxane5000cts, Oxane5700cts and Densiron 68 
(Heavy Silicone Oil {HSO}) were utilised as a 
vitreous substitute in 89 cases of retinal detachment. 
Seventeen patients were excluded because of lack 
of comparative data. 
Seventy-two (72) cases of retinal detachments 
were used for the purpose of this study. Twenty-six 
patients fell into the rhegmatogenous retinal 
detachments (RRD) group, while the diabetic 
tractional retinal detachments (DTRD) and complex 
retinal detachments (CRD) groups included 
nineteen and twenty-seven patients respectively. 
Patients suffering from multiple retinal tears, 
proliferative vitreoretinopathy and large inferior 
retinal tears were included within the CRD group. 
 The study was approved by the appropriate 
patient safety and ethics approval boards. Strict 
inclusion and exclusion criteria were established. 
The surgical register at Mater Dei Hospital Malta 
was used as the source of all the data for surgical 
patients undergoing retinal detachment repair. Data 
of procedures performed by the same consultant 
vitreoretinal surgeon between the years 2007 and 
2013 was used. Eighty nine (89) patients were 
reviewed from which data on primary pathology, 
type of SO, duration of oil “in situ” and 
complications (including emulsification, increased 
intraocular pressure (IOP), re-detachment, cataract 
and presence of CME) were compiled. Of this 
number, seventy two (72) patients with post 
operative follow-up of two years or more and 
documentation of the above parameters were 
included in this study.  
Patients in which 5000cts and 5700cts SO was 
used were grouped together in view of the fact that 
the structural make up was essentially identical 
(Table 1). 
The data was carefully analysed in an effort to 
determine the primary factor or factors responsible 
for the successful or non-successful re-attachment 
of the retina. 
 
Table 1: Representation of the various silicone oils used and their individual properties 
 
Results 
Retinal re-detachment rate is greater when SO 
is removed before 12 months (Table 2). The overall 
re-detachment rate in this series was 26.4%. SO “in 
situ” for 12 months or less resulted in a re-
detachment rate of 18.1% and a re-detachment rate 
of 8.3% for all cases where SO was present for 
greater than 12 months (Table 2). Of the complex 
cases, 61.5% re-detached when SO was left “in 
situ” for less than 12 months and 38.5% re-detached 
when SO was “in situ” for greater than 12 months 
(Table 3). Of the non-complex cases, 83.3% re-
detached on removal of SO at less than 12 months 
and 16.7% re-detached when SO was retained for 
longer than 12 months (Table 3). 
Complex vs non-complex retinal re-
Properties of Silicone Oils 
Oil Density (g/cm3) Viscosity (mPa.s) Surface Tension (mN-m) Refractive Index 
 
Oxane1300 0.98 1000 44.9 1.4 
Oxane5000 0.975 5000 43.01 1.4035 
Oxane5700 0.98 5000 44.9 1.4 
Densiron 68 - HSO 1.06 1500 40.82 1.387 
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detachments in sub-group analysis indicated the 
superiority of retention of SO for greater than 12 
months (Table 3).  Complex cases making use of 
1300cts SO had a re-detachment rate of 15.4% 
when kept “in situ” for less than 12 months 
compared to a re-detachment rate 7.7% when 
retained for longer than 12 months (Table 3). 
5000/5700 and Heavy SO however had a re-
detachment rate of 46.2% when retained for less 
than 12 months and 30.8% when longer than 12 
months (Table 3). Furthermore, separation into 
presence or absence of PVR supports the recognised 
poor success rate of re-attachment in cases of severe 
PVR (Tables 4). 
 
 
Table 2: Representation of the various silicone oils used, their re-detachment rates and the time in situ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Sub-analyses of the re-detachment rate of complex and non-complex cases per silicone oil used 
separated in a period of < or > 12. This shows a greater rate of detachments in the period less than 12 months 
irrespective of whether the detachment was complex or non-complex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retinal Re-Detachment vs 
Duration Silicone Oil "in situ" 
Silicone Oil #Pts Duration of Oil in 
Situ 
<12Mo >12Mo 
1300 cts 34 2 1 
5000/5700 cts 31 9 5 
Densiron 58 - HSO 7 2 0 
  
Total 72 13 6 
Total Percent   18.1 8.3 
Retinal Re-detachment vs Duration Silicone Oil "in 
situ" 
Sub-set Analysis 
Silicone Oil Complex RD Non-Complex RD 
<12Mo >12Mo <12Mo >12Mo 
 
1300 cts 2 1 0 0 
5000/5700 cts 5 4 4 1 
Densiron 58 - HSO 1 0 1 0 
 
        
Sub-total 8 5 5 1 
Total 13 6 
Total Percent 61.5 38.5 83.3 16.7 
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Table 4: Sub-group analyses showing presence of PVR primary cause for decreased detachment rate in 
complex group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total emulsification rate in the series was 
18.1%. Emulsification is greater with low viscosity 
SO (1300cts) resulting in minimal consequences. 
1300cts SO retained for less than 12 months 
accounted for 15.4% of emulsification cases and 
53.8% of cases if retained for longer than 12 
months. 5000/5700 and Heavy SO accounted for 
7.7% of emulsification cases when retained for less 
than 12 months and 23.1% when retained for longer 
than 12 months.  
Total increased IOP rate in the series was 
30.6%. Increased IOP is greater with 5000/5700 cts 
Silicone oil as opposed to 1300cts. 1300cts 
accounted for 36.4% of cases of increased IOP 
when retained for less than 12 months and 4.6% 
when “in situ” for longer than 12 months. 
5000/5700 and Heavy SO “in situ” accounted for 
18.1% of increased IOP cases when retained for less 
than 12 months and 40.9% when retained for longer 
than 12. 
 
Discussion 
Silicone oil is a non-expansible clear fluid, 
commonly used in the treatment of retinal 
detachment, providing a safe, inert medium to 
provide endotamponade.6   Silicone oil has served as 
a vitreous substitute for many years. Numerous 
studies have been performed to identify the 
beneficial effects of silicone oil tamponade whilst 
also establishing the chemical and physiological 
properties which may be applied to different clinical 
scenarios.  
Silicone oil management is not without 
complications. One of the most commonly seen 
complications with the use of silicone oil is 
emulsification.7 Emulsification rates usually vary 
from anything between 17.2% - 38.4% from the 
literature reviewed, occurring in 18.1% of patients 
within our series.8 Emulsification may occur 
between 5 months to anything up to 24months, 
usually occurring within the 1st year or so.9 
Emulsification in itself is clinically significant 
because of the structural and physiological 
implications it has on the functioning of the eye. 
Emulsification refers to the inability of small 
bubbles to coalesce into larger bubbles after 
dispersion from the main silicone oil body has 
occurred. Such a phenomenon results from the 
alteration in oil surface tension, changes in oil 
viscosity as well as prolonged duration of said oil 
“in situ.” Intrinsic surfactants such as fibrin, 
fibrinogen and serum, resulting from intra-ocular 
manipulation, cause a decrease in surface tension, 
resulting in increased droplet dispersion and 
ultimately increased emulsification.10-12 Several 
studies have also shown that less viscous silicone 
oils emulsify faster than oils with greater 
viscosities. Our series demonstrates that the highest 
rate of silicone oil emulsification was also seen in 
the 1300cts group, comprising 69.1% of all cases of 
emulsification. 
When selecting silicone oil, one must balance 
the benefits of prolonged tamponade with the risks 
posed by emulsification of the oil itself. While low 
Complex RD +/- PVR 
  
    
  
Pathology Silicone Oil #Pts % Attached % Detached 
Complex RD +PVR 
1300 9 4 69.2 30.8 
50/57 5 6 45.5 54.5 
Heavy 2 1 66.7 33.3 
Group Total   16 11 59.3 40.7 
            
Complex RD - PVR 
1300 9 1 90 10 
50/57 5 2 71 29 
Heavy 2 0 100 0 
Group Total   16 3 84.2 15.8 
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viscosity silicone oils are usually selected because 
they are easier to handle surgically being easier and 
faster to inject and remove via a small-gauge 
system, higher viscosity silicone oils are subject to 
decreased and delayed emulsification.13 Results 
from our study reveal that 69.2% of all cases of 
emulsification occurred when using 1300cts SO, 
with the rest of the cases being distributed amongst 
SO of greater viscosities. It may hence be argued 
that SO of greater viscosity results in longer lasting 
tamponade, secondary to delayed rate of 
emulsification, which is why they are more 
commonly used in cases of complex retinal 
detachment.  
Although surface tension and viscosity 
influence the rate of emulsification, it is the 
duration of silicone oil “in situ” which has the 
strongest influence on the occurrence of 
emulsification.14 Emulsification may occur between 
5 months to anything up to 24months, usually 
occurring within the 1st year or so. Results from our 
series reveal that 23.1% of all cases of 
emulsification occurred before 12 months of SO “in 
situ”, while 76.9% of cases occurred when SO was 
retained for greater than 12 months. That being 
said, it should be noted that silicone oils of various 
viscosities have similar tamponading effects as long 
as emulsification of the oil has not taken place.15-16 
From conclusions made in our study, the rate 
of re-detachments is significantly increased if 
silicone oil is removed before 12 months. 
Unfortunately, most surgeons insist on retaining SO 
for no longer than 12 months, in an attempt to 
reduce complications associated with SO “in situ”, 
one of which includes emulsification.  
Another commonly faced complication 
associated with the use of SO is the fluctuation of 
intra-ocular pressure (IOP). IOP was increased in 
30.6% of all patients within this series with 54.5% 
of cases being in patients where SO was retained for 
less than 12 months and 45.5% of cases where SO 
was “in situ” for greater than 12 months. Our values 
are greater than average values in other studies, 
which range from 1.5% to 27.7%.17 Although SO 
with greater viscosity are more likely to result in 
increases in IOP, no statistical difference was seen 
with the patients in our series.  
The benefits of silicone oil extraction must be 
outweighed by the risk of retinal re-detachment. 
The results of this study regarding the similarity of 
various SO viscosities in retinal re-attachment rates 
are comparable to the findings of published studies 
present in the ophthalmic literature on an 
international scale. The overall re-detachment rate 
in our series was that of 26.4%, comparable to a 
similar study by Soheilein et.al, quoting a re-
detachment rate of 28%.18 That being said, retinal 
re-detachment rates are quoted in the literature to 
lye anywhere between 9% and 34%, with such 
discrepancies being due to the number of patients 
studied or the underlying disease.19 
The findings of this limited retrospective 
study support the hypothesis that it is the duration 
of the SO “in situ” as opposed to the viscosity or 
other SO attributes which influences the re-
detachment rate. Our findings support that a 
minimum period of 12 months for SO retention “in 
situ” is associated with a higher rate of re-
attachment. In a similar study by Falkner et.al, it 
was felt that after a period of 3-6 months, the 
chances of retinal re-detachment after silicone oil 
removal were minimal.20 While this may hold some 
ground, our findings push us to postulate that a 
period 12 months or more reduce the rates of re-
detachment significantly. 
It is interesting to note that whilst most studies 
in the literature have shown no real difference 
between the tamponading effects of silicone oils of 
varying viscosities, our limited study highlights a 
significantly higher re-detachment rate in the 
5000cts silicone oil when compared to other 
viscosities used. Also of note is that complex retinal 
re-detachment case success is similar to other 
categories when PVR is excluded (Table 4). 
Comparable results were also obtained by Mazareei 
et.al, where higher rates of re-detachments were 
found in the rhegmatogenous retinal detachment 
group with PVR treated with 5000cts silicone oil.21 
Such findings suggest that the higher re-detachment 
rate in the 5000cts group was not due to the 
viscosity of the oil itself, but due to the underlying 
complex pathology for which 5000cts oil is used, 
where residual traction and re-development of 
proliferative vitreoretinopathy could have led to re-
opening or formation of new retinal breaks and the 
ultimate re-detachment.22-23 
The ultimate goal for all retinal surgeons is to 
establish a stable, re-attached retina, free from any 
risk factors that may promote its re-detachment. 
Whilst the possibility of this may be increased by 
silicone oil with greater viscosity, this must be 
balanced by the greater risk of failure within that 
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sub group.  
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